DPP4 and type 2 diabetes mellitus: With nearly two decades of clinical experience, dipeptidyl peptidase-4 (DPP-4) inhibitors are a well-established class of oral hypoglycemic agents, offering clinicians a safe and effective therapeutic option in the multifaceted management of T2DM [1,7].